Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 3 papers. Top paper: “Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells”.
Vivek Anand, Fouad El-Dana, Khoa Nguyen, Yiming Cai, Shirong Cai +6 more
Appalaraju Jaggupilli, Stanley Ly, Bin Yuan, Fouad El-Dana, Venkatesh L. Hegde +13 more
Kenneth Aldape, Zied Abdullaev, Sameer A. Sheth, Jacob Mandel, Hsiang‐Chih Lu +1 more